Jennifer Cann Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
News ICER identifies new crop of 'unsupported' drug price rises Gilead Sciences, Johnson & Johnson, Novartis, Exelixis, and Pfizer have been taken to task by ICER for price increases without new clinical evidence.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
